Negotiating Drug Prices for Medicare: Litigation, Policy, and the Inflation Reduction Act

Please join the Solomon Center for a panel discussion on the Inflation Reduction Act and billion-dollar Medicare drug price negotiations between the federal Department of Health & Human Services and pharmaceutical companies. 

• James (Jim) Stansel ’97’- Executive Vice President and General Counsel of Pharmaceutical Research and Manufactures of America (PhRMA)
• Joel McElvain - Acting Deputy General Counsel, Office of the General Counsel of the U.S. Department of Health and Human Services (HHS)
• Michael F. Cannon - Director of Health Policy Studies of the Cato Institute 

Non-pizza lunch will be served. 

Registration is required for those in the broader Yale Community.